Paroxetine Hydrochloride
These highlights do not include all the information needed to use PAROXETINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PAROXETINE EXTENDED-RELEASE TABLETS. PAROXETINE extended-release tablets, USP, for oral use Initial U.S. Approval: 1992
f22886f5-230c-47e4-9dd8-ffb14c8d6ae4
HUMAN PRESCRIPTION DRUG LABEL
Aug 22, 2023
Lannett Company, Inc.
DUNS: 006422406
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Paroxetine Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Paroxetine Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
Paroxetine Hydrochloride
Product Details
FDA regulatory identification and product classification information